Suppr超能文献

二尖瓣干预后的生活质量。

Quality of life after mitral valve intervention.

作者信息

Tan Matthew K H, Jarral Omar A, Thong Elizabeth H E, Kidher Emaddin, Uppal Rakesh, Punjabi Prakash P, Athanasiou Thanos

机构信息

Department of Surgery and Cancer, Imperial College London, London, UK.

Department of Cardiothoracic Surgery, St. Bartholomew's Hospital, London, UK.

出版信息

Interact Cardiovasc Thorac Surg. 2017 Feb 1;24(2):265-272. doi: 10.1093/icvts/ivw312.

Abstract

Advancements in surgical technique and understanding of the pathophysiology of mitral valve (MV) dysfunction have led to improved outcomes. Seen as a development beyond measures of morbidity and mortality, health-related quality-of-life (HRQOL) outcome measures are becoming increasingly popular. These measures are important because complications following routine (i.e. low-risk) operations on the MV are uncommon and further markers of outcome are needed. Surgeons are increasingly operating earlier on asymptomatic patients and will need to prove that HRQOL is not impacted. Novel minimally invasive and transcatheter technologies will also need to demonstrate satisfactory HRQOL outcomes prior to widespread use. This systematic review provides an overview of all available literature detailing HRQOL in patients receiving MV interventions. In the 43 studies included, 6865 patients underwent procedures ranging from open replacement to percutaneous repair using devices such as the Mitraclip Clip Delivery System (MitraClip) (Abbott Vascular, Santa Clara, CA, USA). Most studies performed baseline HRQOL assessment, allowing postinterventional comparison. While the underlying literature had deficiencies, most studies report acceptable postintervention HRQOL that was comparable to that of matched general populations. Patient-specific (e.g. female gender, renal dysfunction) and surgical-specific factors (e.g. replacement instead of repair, elevated transmitral gradient) were identified that predispose patients to poorer long-term HRQOL outcomes. These factors are important for clinicians developing strategies to maximize their HRQOL outcomes. Future randomized studies would benefit from HRQOL measurements at specific time points to allow large-scale comparisons. Establishing a common HRQOL instrument for use in MV intervention studies may support detailed comparisons between specific techniques. Physical activity monitors, physiological biomarkers and radiological markers could also be used as innovative indicators of functional outcome.

摘要

手术技术的进步以及对二尖瓣(MV)功能障碍病理生理学认识的提高,带来了更好的治疗效果。健康相关生活质量(HRQOL)作为一种超越发病率和死亡率衡量指标的发展成果,正变得越来越受欢迎。这些指标很重要,因为MV常规(即低风险)手术后的并发症并不常见,还需要更多的预后指标。外科医生越来越早地对无症状患者进行手术,并且需要证明HRQOL不受影响。新型微创和经导管技术在广泛应用之前,也需要证明其能带来令人满意的HRQOL结果。本系统评价概述了所有详细阐述接受MV干预患者HRQOL的现有文献。在纳入的43项研究中,6865例患者接受了从开放置换到使用诸如MitraClip夹合输送系统(MitraClip)(美国加利福尼亚州圣克拉拉市雅培血管公司)等器械进行经皮修复等各种手术。大多数研究进行了基线HRQOL评估,以便进行干预后比较。尽管相关文献存在不足,但大多数研究报告干预后的HRQOL可接受,与匹配的普通人群相当。已确定患者特异性因素(如女性、肾功能不全)和手术特异性因素(如置换而非修复、跨二尖瓣压差升高)会使患者长期HRQOL预后较差。这些因素对于临床医生制定使患者HRQOL结果最大化的策略很重要。未来的随机研究若在特定时间点进行HRQOL测量,将有助于进行大规模比较。建立一种用于MV干预研究的通用HRQOL工具,可能有助于对特定技术进行详细比较。身体活动监测器、生理生物标志物和放射学标志物也可用作功能预后的创新指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验